There are several reports indicating that erythropoietin, HU (an Hb F augmenting agent), and Minihepcidin Peptide or similar drugs (ACE-536, ACE-011), which promote RBC differentiation or maturation in the bone marrow improve anemia  64-67 . Here, GSTM1 is linked to anemia (phenotype).